The American Society for Pharmacology and Experimental Therapeutics, a FASEB member society, will end page charges for new submissions from all authors who opt-in for Open Access.
news, journals and articles from all over the world.
The American Society for Pharmacology and Experimental Therapeutics, a FASEB member society, will end page charges for new submissions from all authors who opt-in for Open Access.